These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3127273)

  • 1. Expression of antibody cDNA in murine myeloma cells: possible involvement of additional regulatory elements in transcription of immunoglobulin genes.
    Weidle UH; Koch S; Buckel P
    Gene; 1987; 60(2-3):205-16. PubMed ID: 3127273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between immunoglobulin enhancers and promoters.
    Garcia JV; Bich-Thuy LT; Stafford J; Queen C
    Nature; 1986 Jul 24-30; 322(6077):383-5. PubMed ID: 3016550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of immunoglobulin control elements in transgenic mice.
    Miller AE; Ennist DL; Ozato K; Westphal H
    Immunogenetics; 1992; 35(1):24-32. PubMed ID: 1729170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intron sequences on expression levels of Ig cDNAs.
    Khamlichi AA; Rocca A; Cogné M
    Gene; 1994 Dec; 150(2):387-90. PubMed ID: 7821812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
    Singh H; Sen R; Baltimore D; Sharp PA
    Nature; 1986 Jan 9-15; 319(6049):154-8. PubMed ID: 3079885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells.
    Weidle UH; Borgya A; Mattes R; Lenz H; Buckel P
    Gene; 1987; 51(1):21-9. PubMed ID: 3110010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both immunoglobulin promoter and enhancer sequences are targets for suppression in myeloma-fibroblast hybrid cells.
    Junker S; Nielsen V; Matthias P; Picard D
    EMBO J; 1988 Oct; 7(10):3093-8. PubMed ID: 3141146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.
    Fulton R; van Ness B
    Nucleic Acids Res; 1994 Oct; 22(20):4216-23. PubMed ID: 7937148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two regulatory elements for immunoglobulin kappa light chain gene expression.
    Bergman Y; Rice D; Grosschedl R; Baltimore D
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7041-5. PubMed ID: 6438631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.
    Fulton R; Van Ness B
    Nucleic Acids Res; 1993 Oct; 21(21):4941-7. PubMed ID: 8177743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunoglobulin promoter displays cell-type specificity independently of the enhancer.
    Foster J; Stafford J; Queen C
    Nature; 1985 May 30-Jun 5; 315(6018):423-5. PubMed ID: 3923370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor NF-kappa B can interact functionally with its cognate binding site to provide lymphoid-specific promoter function.
    Wirth T; Baltimore D
    EMBO J; 1988 Oct; 7(10):3109-13. PubMed ID: 3141147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer.
    Yutzey KE; Konieczny SF
    Nucleic Acids Res; 1992 Oct; 20(19):5105-13. PubMed ID: 1329039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.
    Gillies SD; Morrison SL; Oi VT; Tonegawa S
    Cell; 1983 Jul; 33(3):717-28. PubMed ID: 6409417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extinction of Ig genes expression in myeloma x fibroblast somatic cell hybrids is accompanied by repression of the oct-2 gene encoding a B-cell specific transcription factor.
    Bergman Y; Strich B; Sharir H; Ber R; Laskov R
    EMBO J; 1990 Mar; 9(3):849-55. PubMed ID: 2107075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.
    Roman C; Platero JS; Shuman J; Calame K
    Genes Dev; 1990 Aug; 4(8):1404-15. PubMed ID: 2121606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site.
    Pelletier MR; Hatada EN; Scholz G; Scheidereit C
    Nucleic Acids Res; 1997 Oct; 25(20):3995-4003. PubMed ID: 9321649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem kappa immunoglobulin promoters are equally active in the presence of the kappa enhancer: implications for models of enhancer function.
    Atchison ML; Perry RP
    Cell; 1986 Jul; 46(2):253-62. PubMed ID: 3087628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-type preference of immunoglobulin kappa and lambda gene promoters.
    Picard D; Schaffner W
    EMBO J; 1985 Nov; 4(11):2831-8. PubMed ID: 2998757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.